The growth of Real World Evidence Solutions Market is primarily driven by the increased R&D spending for the development of new pharmaceutical products and medical devices and support from regulatory bodies for the use of RWE solutions. Additionally, rising geriatric population, subsequent increase in the prevalence of chronic diseases, shift from volume- to value-based care, delays in drug development and the subsequent increase in development costs are some of the other major factors that are driving the growth of this market.
0
0
